# Disseminated Musculoskeletal Coccidioidomycosis in an Immunocompetent Host: A Rare Case Requiring Extensive Spinal and Pelvic Surgery

**Authors:** Elangovan Raman, Sorabh Sharma

PMC · DOI: 10.7759/cureus.87716 · Cureus · 2025-07-11

## TL;DR

A healthy man developed severe fungal infection in his bones and required multiple surgeries and strong antifungal treatments.

## Contribution

This case report highlights a rare instance of severe coccidioidomycosis in an immunocompetent individual requiring extensive surgical and medical intervention.

## Key findings

- Disseminated musculoskeletal coccidioidomycosis occurred in an immunocompetent host, involving the spine, pelvis, and chest wall.
- Aggressive surgical and antifungal treatment was necessary, including multiple surgeries and escalation of antifungal therapy.
- The case underscores the need for high clinical suspicion and multidisciplinary management in rare fungal infections.

## Abstract

Coccidioidomycosis, also known as “Valley Fever,” is an endemic fungal infection caused by Coccidioides species, typically presenting as a respiratory illness. Disseminated disease, particularly with extensive skeletal involvement, is rare and typically seen in immunocompromised individuals. We report a unique and severe case of disseminated musculoskeletal coccidioidomycosis in a previously healthy immunocompetent 33-year-old African American man, involving multiple spinal levels, pelvic bones, and the right chest wall. The patient required multiple orthopedic surgeries, including anterior and posterior spinal decompression and fusion, bilateral sacroiliac joint debridement, and pelvic fixation. The diagnosis was confirmed via bone biopsy demonstrating Coccidioides spherules. Despite antifungal therapy, his disease progressed, necessitating escalation of treatment from fluconazole to isavuconazole and liposomal amphotericin B, followed by initiation of fosmanogepix as part of the approved treatment regimen. This case highlights the importance of high clinical suspicion, aggressive surgical intervention, and multidisciplinary management in complex disseminated coccidioidomycosis, even in immunocompetent hosts.

## Linked entities

- **Chemicals:** fluconazole (PubChem CID 3365), isavuconazole (PubChem CID 6918485), liposomal amphotericin B (PubChem CID 44405442), fosmanogepix (PubChem CID 44123754)
- **Diseases:** coccidioidomycosis (MONDO:0005706)
- **Species:** Coccidioides (taxon 5500), Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** Coccidioides (MESH:D003047), fungal infection (MESH:D009181), respiratory illness (MESH:D012140)
- **Chemicals:** amphotericin B (MESH:D000666), isavuconazole (MESH:C508735), fosmanogepix (-), fluconazole (MESH:D015725)
- **Species:** Coccidioides (genus) [taxon 5500], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12335751/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12335751/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12335751/full.md

---
Source: https://tomesphere.com/paper/PMC12335751